GMCM
AMPE

Gruber & McBaine Capital Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Gruber & McBaine Capital Management’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-400
Closed -$904K – 206
2015
Q1 		$904K Buy
+400
New +$682K 0.24% 118
2014
Q3 		– Sell
-100
Closed -$251K – 219
2014
Q2 		$251K Hold
100
– – 0.07% 183
2014
Q1 		$191K Buy
+100
New +$236K 0.05% 182

Other funds holding AMPE

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
NFG
Noven Financial Group Denver, Colorado $123M AUM 5.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Gruber & McBaine Capital Management's AMPE Position: Q2 2015 in Review

Gruber & McBaine Capital Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2015, closing a stake of 400 shares — an estimated $904K sold.

Gruber & McBaine Capital Management first reported a position in AMPE in Q1 2014 and held it in 3 quarters. The position peaked at $904K in Q1 2015. 64 funds tracked by Wall St. Rank hold AMPE as of Q2 2015.

  • Gruber & McBaine Capital Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2015 after selling out during the quarter.
  • Gruber & McBaine Capital Management sold 400 Ampio Pharmaceuticals Inc. shares in Q2 2015, an estimated $904K.
  • Gruber & McBaine Capital Management first reported a position in Ampio Pharmaceuticals Inc. in Q1 2014 and held it in 3 quarters.
  • Gruber & McBaine Capital Management's Ampio Pharmaceuticals Inc. position peaked at $904K in Q1 2015.
  • 64 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2015.

Based on Gruber & McBaine Capital Management's 13F filing for Q2 2015, filed 13 Aug 2015.